131 related articles for article (PubMed ID: 38899570)
1. tPA supplementation preserves neurovascular and cognitive function in Tg2576 mice.
Uekawa K; Anfray A; Ahn SJ; Casey N; Seo J; Zhou P; Iadecola C; Park L
Alzheimers Dement; 2024 Jun; ():. PubMed ID: 38899570
[TBL] [Abstract][Full Text] [Related]
2. tPA Deficiency Underlies Neurovascular Coupling Dysfunction by Amyloid-β.
Park L; Zhou J; Koizumi K; Wang G; Anfray A; Ahn SJ; Seo J; Zhou P; Zhao L; Paul S; Anrather J; Iadecola C
J Neurosci; 2020 Oct; 40(42):8160-8173. PubMed ID: 32928888
[TBL] [Abstract][Full Text] [Related]
3. Border-associated macrophages promote cerebral amyloid angiopathy and cognitive impairment through vascular oxidative stress.
Uekawa K; Hattori Y; Ahn SJ; Seo J; Casey N; Anfray A; Zhou P; Luo W; Anrather J; Park L; Iadecola C
Mol Neurodegener; 2023 Oct; 18(1):73. PubMed ID: 37789345
[TBL] [Abstract][Full Text] [Related]
4. Border-associated macrophages promote cerebral amyloid angiopathy and cognitive impairment through vascular oxidative stress.
Uekawa K; Hattori Y; Ahn SJ; Seo J; Casey N; Anfray A; Zhou P; Luo W; Anrather J; Park L; Iadecola C
Res Sq; 2023 Apr; ():. PubMed ID: 37162996
[No Abstract] [Full Text] [Related]
5. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
Bi Oh S; Suh N; Kim I; Lee JY
Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
[TBL] [Abstract][Full Text] [Related]
6. Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy.
Shin HK; Jones PB; Garcia-Alloza M; Borrelli L; Greenberg SM; Bacskai BJ; Frosch MP; Hyman BT; Moskowitz MA; Ayata C
Brain; 2007 Sep; 130(Pt 9):2310-9. PubMed ID: 17638859
[TBL] [Abstract][Full Text] [Related]
7. Zinc-triggered induction of tissue plasminogen activator and plasminogen in endothelial cells and pericytes.
Cho MK; Sun ES; Kim YH
Exp Neurobiol; 2013 Dec; 22(4):315-21. PubMed ID: 24465147
[TBL] [Abstract][Full Text] [Related]
8. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
9. Tissue plasminogen activator arrests Alzheimer's disease pathogenesis.
Oh SB; Byun CJ; Yun JH; Jo DG; Carmeliet P; Koh JY; Lee JY
Neurobiol Aging; 2014 Mar; 35(3):511-9. PubMed ID: 24126163
[TBL] [Abstract][Full Text] [Related]
10. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of tPA/plasminogen proteolytic system in the periphery of amyloid deposits in the Tg2576 mouse model of Alzheimer's disease.
Lee JY; Kweon HS; Cho E; Lee JY; Byun HR; Kim DH; Kim YH; Han PL; Koh JY
Neurosci Lett; 2007 Aug; 423(1):82-7. PubMed ID: 17662525
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction.
Solis E; Hascup KN; Hascup ER
J Alzheimers Dis; 2020; 76(4):1179-1198. PubMed ID: 32597813
[TBL] [Abstract][Full Text] [Related]
13. Age-dependent neurovascular dysfunction and damage in a mouse model of cerebral amyloid angiopathy.
Park L; Koizumi K; El Jamal S; Zhou P; Previti ML; Van Nostrand WE; Carlson G; Iadecola C
Stroke; 2014 Jun; 45(6):1815-21. PubMed ID: 24781082
[TBL] [Abstract][Full Text] [Related]
14. Innate immunity receptor CD36 promotes cerebral amyloid angiopathy.
Park L; Zhou J; Zhou P; Pistick R; El Jamal S; Younkin L; Pierce J; Arreguin A; Anrather J; Younkin SG; Carlson GA; McEwen BS; Iadecola C
Proc Natl Acad Sci U S A; 2013 Feb; 110(8):3089-94. PubMed ID: 23382216
[TBL] [Abstract][Full Text] [Related]
15. Hypertension enhances Aβ-induced neurovascular dysfunction, promotes β-secretase activity, and leads to amyloidogenic processing of APP.
Faraco G; Park L; Zhou P; Luo W; Paul SM; Anrather J; Iadecola C
J Cereb Blood Flow Metab; 2016 Jan; 36(1):241-52. PubMed ID: 25920959
[TBL] [Abstract][Full Text] [Related]
16. STAT3 inhibitor mitigates cerebral amyloid angiopathy and parenchymal amyloid plaques while improving cognitive functions and brain networks.
Mehla J; Singh I; Diwan D; Nelson JW; Lawrence M; Lee E; Bauer AQ; Holtzman DM; Zipfel GJ
Acta Neuropathol Commun; 2021 Dec; 9(1):193. PubMed ID: 34911575
[TBL] [Abstract][Full Text] [Related]
17. Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer's disease.
Apátiga-Pérez R; Soto-Rojas LO; Campa-Córdoba BB; Luna-Viramontes NI; Cuevas E; Villanueva-Fierro I; Ontiveros-Torres MA; Bravo-Muñoz M; Flores-Rodríguez P; Garcés-Ramirez L; de la Cruz F; Montiel-Sosa JF; Pacheco-Herrero M; Luna-Muñoz J
Metab Brain Dis; 2022 Jan; 37(1):39-50. PubMed ID: 34406560
[TBL] [Abstract][Full Text] [Related]
18. Cerebral arteriolar and neurovascular dysfunction after chemically induced menopause in mice.
Blackwell JA; Silva JF; Louis EM; Savu A; Largent-Milnes TM; Brooks HL; Pires PW
Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H845-H860. PubMed ID: 36149767
[TBL] [Abstract][Full Text] [Related]
19. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
Bell RD; Zlokovic BV
Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
[TBL] [Abstract][Full Text] [Related]
20. Long-term voluntary wheel running does not alter vascular amyloid burden but reduces neuroinflammation in the Tg-SwDI mouse model of cerebral amyloid angiopathy.
Robison LS; Popescu DL; Anderson ME; Francis N; Hatfield J; Sullivan JK; Beigelman SI; Xu F; Anderson BJ; Van Nostrand WE; Robinson JK
J Neuroinflammation; 2019 Jul; 16(1):144. PubMed ID: 31296239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
